Ocular Therapeutapeutix, Inc: Chief strategy officer resigns

What happened Ocular Therapeutix, Inc filed a Form 8-K reporting that on Oct 14, 2026 Sanjay Nayak, M.B.B.S., Ph.D., Chief Strategy Officer of the Company, notified the Company of his resignation from the Company, effective Oct 16, 2026, to become the Chief Executive Officer of a privately-held company.

Key details

• Officer: Sanjay Nayak, M.B.B.S., Ph.D., Chief Strategy Officer.
• Notification date: Oct 14, 2026.
• Resignation effective date: Oct 16, 2026.
• Reason stated in the filing: to become the Chief Executive Officer of a privately-held company.

Why it may matter This report was made under Item 5.02: Departure of directors or certain officers; election of directors, which covers filings about changes in officers or directors. The filing does not show why the insider traded or why the company acted.